Isodiol International, Inc. engages in the manufacture and sale of nutritional CBD-based consumer packaged goods. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2014-09-17. The firm supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. The company grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. The company has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The firm's ready to label program offers a range of CBD products ready to be added or developed for various brands. The firm is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Follow-Up Questions
Isodiol International Inc のCEOは誰ですか？
Mr. Marcos Agramont は Isodiol International Inc の Chief Executive Officer で、2017 から在籍しています。
ISOLF の株価パフォーマンスは？
ISOLF の現在の価格は $0 で、最終取引日から 0% decreased 変動しました。
Isodiol International Inc の主な事業テーマや業界は？
Isodiol International Inc は Pharmaceuticals 業界、セクターは Health Care に属しています。
